Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011-2014)
{{output}}
Introduction: There is a continuous need for next-generation non-nucleoside RT inhibitors (NNRTIs) with different resistance profiles, improved safety, excellent tolerability, and favorable physicochemical properties. ... ...